1536
Y. Sun et al. / Polymer 53 (2012) 1535e1542
(w20 nm) and in film (w30 nm). Cyclic voltammetry measure-
ments of the two polymers indicated that polymer PCTTBTC12
possessed the similar HOMO level and deeper LUMO level
compared to the polymer PCTBTC8. BHJ polymer solar cell devices
were fabricated based on the synthesized two polymers as donor
and PC71BM as acceptor. As expected, the incorporation of the fused
thieno thiophene ring as the linker group between the donor and
acceptor units in the polymer chain lead to the significantly
improved current density and hence device efficiency. In addition,
the hole only device also indicated that the polymer PCTTBTC12
possessed enhanced hole mobility than PCTBTC8. The relationships
between the photovoltaic properties with the UVevis absorption,
energy levels, film morphology and hole mobility are discussed in
details.
temperature, the reaction mixture was poured into water (100 mL).
Organic layer was separated and water phase was extracted with
dichloromethane for three times. The combined organic layer was
washed with brine (30 mL) and dried over anhydrous magnesium
sulfate. The residue was chromatographically purified on silica gel
column eluting with CH2Cl2:hexane (1:12, v:v) to afford the
compound 1 as a yellow oil (968 mg, 87%).1HNMR (CDCl3, ppm):
d
¼ 8.47 (dd, J ¼ 3.7 Hz, 2H), 7.51 (dd, J ¼ 6.3 Hz, 2H), 7.27e7.22 (m,
2H), 4.11 (t, J ¼ 7.1 Hz, 4H), 1.97e1.87 (m, 4H), 1.67e1.20 (m, 20H),
0.98e0.87 (m, 6H). 13C NMR (CDCl3):
d
¼ 152.32, 151.38, 134.57,
131.02, 127.68, 127.14, 118.03, 74.75, 32.44, 30.85, 30.22, 30.16,
30.08, 29.89, 28.76, 27.25, 26.47, 23.21, 17.69, 14.63, 14.09.
2.3.2. 4, 7-bis (5-bromothiophen-2-yl)-5, 6-bis (octyloxy) benzo[c]
[1,2,5] thiadiazole (compound 2)
2. Experimental part
NBS (653 mg, 3.67 mmol) was added in one portion to a solution
of compound 1 (1 g, 1.80 mmol) in DMF (15 mL). The mixture was
stirred at room temperature for 20 h in the dark. After that, solvent
was removed under reduced pressure and the residue was chro-
matographically purified on silica gel column eluting with
CH2Cl2:hexane (1:12, v: v) to afford3as an orange solid (1.15 g,
2.1. Materials
4,7-Dibromo-5,6-bis (octyloxy) benzo-2,1,3-thiadiazole, 4,7-
Dibromo-5,6-bis
(dodecyloxy)-benzo-2,1,3-thiadiazole,4,7-bis
(thieno[3,2-b]thiophen-2-yl)-2,1,3-benzothiadiazole, 2-(tributyl-
stannyl) thieno[3,2-b]thiophene and 2,7-Bis (4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)-N-9-heptadecanylcarbazole (compound
5) were prepared according to literature procedures [17e19]. All
other chemical reagents were purchased from Aldrich or TCI and
used without further purification. Toluene and tetrahydrofuran
(THF) were purified by distillation from sodium under nitrogen
atmosphere using benzophenone as an indicator. N, N-dime-
thylformamide (DMF) was distilled under vacuum after dried over
CaH2.
90%).1H NMR (CDCl3):
2H), 4.13 (t, J ¼ 7.1 Hz, 4H), 2.18e1.97 (m, 4H), 1.52e1.20 (m, 20H),
0.88 (m, 6H). 13C NMR (CDCl3):
d
¼ 8.37 (d, J ¼ 4.1 Hz, 2H), 7.18 (d, J ¼ 4.1 Hz,
d
¼ 151.75, 150.67, 136.07, 131.41,
130.04, 117.30, 115.88, 74.91, 32.30, 30.77, 29.97, 29.77, 26.41, 23.17,
14.61.
2.3.3. 5, 6-bis (dodecyloxy)-4, 7-di (thieno[3,2-b] thiophen-2-yl)
benzo-[c] [1,2,5]-thiadiazole (compound 3)
4,7-Dibromo-5,6-bis(dodecyloxy)-benzo-2,1,3-thiadiazole
(1.33 g, 2 mmol) and 2-(tributylstannyl) thieno[3,2-b] thiophene
(2.15 g, 5 mmol) were dissolved in dry THF and then the mixture
was added the catalyst of tris(dibenzylideneacetone) dipalladium
(0) (55 mg) and tri(o-tolyl) phosphine (137 mg). Then the reaction
was refluxed for 20 h under N2. After cooling to room temperature,
the mixture solution was poured into water (100 mL) and organic
layer was separated. Water phase was extracted with dichloro-
methane for three times. The combined organic layer was washed
with brine (30 mL) and dried over anhydrous magnesium sulfate.
The residue was chromatographically purified on silica gel column
eluting with CH2Cl2:hexane (1:8, v:v) to afford the product
2.2. Measurement and characterization
1H and 13C NMR spectra were recorded on Bruker AV 300 or 500
spectrometers operating at 300 or 125 MHz in CDCl3. ESI-MS spectra
tests were performed using a Bruker APEX Qe 47e fourier transform
(ion cyclotron resonance). Gel permeation chromatography (GPC)
measurements were carried out on a Waters 1515 chromatograph
with a refractive index detector in room temperature with THF as
eluent. UVevis spectra were obtained using a PerkineElmer
Lambda-9 spectrophotometer. The differential scanning calorim-
etry (DSC) tests was testeꢁd1 by DSC2010 (TA instruments) with
compound 3 as red solid (702 mg, 45%).1H NMR (CDCl3):
d
¼ 8.82 (s,
2H), 7.48 (d, J ¼ 5.2 Hz, 2H), 7.35 (d, J ¼ 5.2 Hz, 2H), 4.18 (t, J ¼ 7.1 Hz,
a heating rate of 10 ꢀC min and a nitrogen flow of 50 mL minꢁ1
.
4H), 2.02e1.94 (m, 4H), 1.52e1.10 (m, 36H), 0.91 (m, 6H). 13C NMR
Thermogravimetric analysis (TGA) was performed on
a
Per-
(CDCl3):
d
¼ 153.21, 151.64, 138.79, 137.69, 135.79, 122.67, 121.23,
kineElmer TGA-7.Cyclic voltammetries (CV) measurement were
conducted on a BAS CV-50W voltammetric system with a three-
electrode cell in acetonitrile with 0.1 M of tetrabutylammonium
hexafluorophosphate using a scan rate of 100 mV sꢁ1 with ITO, Ag/
AgCl and Pt mesh as the working electrode, reference electrode and
counter electrode, respectively. The photoluminescence (PL) spectra
of the samples were measured on a FluoroLog 3-TCSPC spectro-
photometer. AFM images were obtained on a Veeco multimode AFM
with a Nanoscope III controller under tapping mode.
120.21, 116.89, 75.11, 32.72, 30.89, 30.11, 29.91, 29.72, 26.36, 23.21,
14.78.
2.3.4. 4, 7-bis (5-bromo-thieno [3, 2-b] thiophen-2-yl)-5, 6-bis
(dodecyloxy) benzo[c] [1,2,5]thiadiazole (compound 4)
The compound 3 (702 mg, 0.90 mmol) was dissolved in DMF
(10 mL) and then NBS (384 mg, 2.16 mmol) was added to the
solution in one portion. The mixture solution was stirred at room
temperature for 20 h in the dark. Solvent was removed under
reduced pressure and the residue was chromatographically purified
on silica gel column eluting with CH2Cl2:hexane (1:6, v:v) to afford
the compound 4as a red solid (753 mg, 89%).1H NMR (CDCl3):
2.3. Synthesis of monomers and copolymers
2.3.1. 5, 6-bis (octyloxy)-4, 7-di (thiophen-2-yl) benzo-[c] [1,2,5]
thiadiazole (compound 1)
d
¼ 8.76 (s, 2H), 7.33 (s, 2H), 4.15 (t, J ¼ 7.1 Hz, 4H), 1.99e1.91 (m,
4H), 1.52e1.20 (m, 36H), 0.89 (m, 6H).13C NMR (CDCl3):
d
¼ 152.01,
A mixture of 4, 7-Dibromo-5,6-bis (octyloxy) benzo-2,1,3-
thiadiazole (1.10 g, 2 mmol) and tributyl (thiophen-2-yl) stannane
(1.87 g, 5 mmol) were dissolved in dry THF followed by the addition
of tris(dibenzylideneacetone) dipalladium (0) (55 mg) and tri(o-
tolyl) phosphine (137 mg) under N2. Then the resulting mixture
was refluxed for 20 h under N2. After being cooled to room
150.79, 140.42, 139.70, 135.82, 122.67, 122.40, 117.93, 114.89, 74.96,
32.16, 30.57, 29.90, 29.79, 29.61, 26.19, 22.93, 14.35.
2.3.5. PCTBTC8
Compound 5 (264 mg, 0.4 mmol) and compound 2 (284 mg,
0.4 mmol) were dissolved in a mixture of toluene (6 mL) and